Hematology:
Myelodysplastic syndrome — Chemotherapy and immunotherapy. Treatment abroad

The tactics of dealing with myelodysplastic syndrome (MDS) is developed individually, focusing on the patient's condition. Chemotherapy and immune therapy is usually recommended for patients from the group of medium and high risk. In some cases, such treatment is preceded by bone marrow transplantation.

Diagnostic Measures

On the eve of treatment, the patient consults an oncologist. The physician clarifies complaints, conducts clinical examination and prescribes the required tests:

  • complete blood count,
  • blood chemistry,
  • cytogenetic analysis.

Based on the test findings, the optimal dosage regimen is selected.

Procedure

The patient is hospitalized for a period of 16 days. Hypomethylating drugs increasing the duration and improving the quality of the patient’s life are used for treatment.

The studies of MDS pathogenesis showed that the leading role in the disease development is played by changes in the stem cell DNA. This process leads to the appearance of myeloblasts in bone marrow and impaired hematopoiesis. Hypomethylating agents (azacitidine, decitabine) restore the normal structure of DNA, inhibiting the further formation of tumor cells.

The drugs are administered intravenously. As regards side effects, the patients may report:

  • nausea,
  • increased body temperature,
  • reduction of platelet count, red blood cells and neutrophils.

Symptomatic therapy is prescribed to correct this condition.

Patients at high risk can be indicated low doses of cytarabine, a cytostatic. Therapy is also conducted intravenously under medical supervision by the hematologist. The cost of drugs depends on the treatment intensity.

During treatment, the patients receives meticulous care. After cycle completion, the patient is provided recommendations for further action.

Read more
 

Sort by:

University Hospital Bonn

8.6/10 from 150 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The key objective of the Department of Internal Medicine III is to create and offer optimal treatments for internal diseases on inpatient, partially inpatient and outpatient basis.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Bonn

Price 13581.00

University Hospital Cologne

8.7/10 from 82 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department I for Internal Medicine of the University Hospital Cologne deals with the treatment of patients with various internal diseases. This includes in particular the following fields: Oncology, Hematology, Clinical infectology, Clinical immunology, Hemostasis, Intensive care.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Cologne

Price 13285.00

University Hospital Frankfurt

7.5/10 from 97 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Hematology, Oncology, Hemostasis, Rheumatology and Infectology at the University Hospital Frankfurt specializes in the treatment of all diseases of the hymatopoietic system and solid tumors.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Frankfurt am Main

Price 15749.00

Charite University Hospital Berlin

9/10 from 95 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Charité Comprehensive Cancer Center integrates the clinical and research activities for all Charité departments and institutes dealing with Cancer. The director of the Charité Comprehensive Cancer Center is Prof. Dr. med. Ulrich Keilholz.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Berlin

Price 19327.00

University Hospital Heidelberg

9/10 from 57 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Hematology, Oncology and Rheumatology at the Heidelberg University Hospital makes every effort to provide medical care of the highest quality to the patients with oncologic and rheumatologic diseases.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Heidelberg

Krankenhaus Nordwest

9.5/10 from 24 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

Department of Oncology and Hematology of Krankenhaus Nordwest offers a wide range of medical services, including diagnosis, therapy and treatment of oncological diseases or diseases closely associated with the circulatory system.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Frankfurt am Main

Price 12273.00

Städtisches Klinikum Schwabing

8.5/10 from 7 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Hematology, Oncology, Immunology, Palliative Medicine, Infectious Diseases and Tropical Medicine in Schwabing treats all benign blood diseases, disorders of the immune and coagulation system, all forms of blood cancer, and the most of cancers.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Munich

Price 12190.00

RWTH University Hospital Aachen

8.7/10 from 41 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Oncology, Hematology and Stem Cell Transplant provides patient care on both inpatient and outpatient basis. The focuses of the inpatient treatment are acute leukemia and high-dose chemotherapy followed by autologous blood stem cell transplantation.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Aachen

Price 12391.00

Alfried Krupp Hospital in Essen-Ruettenscheid

9.9/10 from 42 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The main treatment areas of the Department of Internal Medicine I, headed by Prof. Dr. med. Thomas Budde, are invasive and non-invasive cardiac diagnostics and therapy of all cardiac diseases.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Essen

Price 11144.00

University Hospital Dusseldorf

9.9/10 from 71 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Hematology, Oncology and Clinical Immunology at the University Hospital Dusseldorf provides treatment of patients with blood diseases, cancer and immune system diseases. The Department focuses on the treatment of malignant diseases of  blood, bone marrow and lymph nodes. .


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Duesseldorf

Price 15479.00

Hannover Medical School, MHH

9.8/10 from 43 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The clinic of hematology, hemostasis, oncology and stem cell transplantation is a leading therapeutic clinic of the Medical Institute of Hannover for patients with solid tumor and systemic diseases, with other partially benign diseases of the hematopoietic system, as well as bleeding disorders.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Hannover

Price 13492.00

Städtisches Klinikum Neuperlach

9.8/10 from 11 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The department of hematology and oncology diagnosed and treated malignant tumors. The therapeutic spectrum includes all medicamentous treating methodes including chemotherapy, antibody, immune and hormone therapy. Cancer patients benefit from interdisciplinary treatment.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Munich

Price 12604.00

Gummersbach District Hospital of the Klinikum Oberberg

9.6/10 from 23 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Internal Medicine II at the Klinikum Oberberg in Gummersbach focuses on diagnosis and treatment of oncological and hematological diseases.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Gummersbach

Price 11424.00

University Hospital Halle (Saale)

9.5/10 from 78 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Department of Internal Medicine IV (Hematology and Oncology) covers the whole range of hematology and oncology. This includes prevention, diagnosis, therapy and post-operative care for cancer of all organs and blood.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Halle

Price 13266.00

UKGM Gießen

9.5/10 from 35 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The department of internal medicine IV and V includes general internal medicine and a number of priority areas of this subject. The clinic offers a wide range of newest innovative treatments especially in the fields of medical oncology, hematology and palliative care.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Giessen

Price 12147.00

University Hospital Hamburg-Eppendorf

9.2/10 from 92 Votes

Chemotherapy and immunotherapy of Myelodysplastic syndrome (mds)

The Medical Department II at the University Medical Center Hamburg-Eppendorf specializes in the treatment of patients with cancer of the internal organs and hematopoietic system. There is provided the whole range of treatments for these diseases.


Duration 14 days
Type of Treatment: Inpatient
location_onCountry: Germany
location_searchingCity: Hamburg

Price 19318.00